MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings
(Alliance News) - MaxCyte Inc on Monday said the current year has been good for the company as it upgraded its core revenue guidance for 2024 and anticipates cost savings for 2025. Read More